Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model

BACKGROUND: Donepezil, galantamine, rivastigmine and memantine are potentially effective interventions for cognitive impairment in dementia, but the use of these drugs has not been personalised to individual patients yet. We examined whether artificial intelligence-based recommendations can identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qiang, Vaci, Nemanja, Koychev, Ivan, Kormilitzin, Andrey, Li, Zhenpeng, Cipriani, Andrea, Nevado-Holgado, Alejo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805393/
https://www.ncbi.nlm.nih.gov/pubmed/35101059
http://dx.doi.org/10.1186/s12916-022-02250-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805393/
https://www.ncbi.nlm.nih.gov/pubmed/35101059
http://dx.doi.org/10.1186/s12916-022-02250-2

Ejemplares similares